174 related articles for article (PubMed ID: 16150811)
1. Current status of hormone therapy and breast cancer.
Norman RJ; MacLennan AH
Hum Reprod Update; 2005; 11(6):541-3. PubMed ID: 16150811
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer risk with postmenopausal hormonal treatment.
Collins JA; Blake JM; Crosignani PG
Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
[TBL] [Abstract][Full Text] [Related]
3. Menopausal hormone therapy and risk of breast cancer: a meta-analysis of epidemiological studies and randomized controlled trials.
Greiser CM; Greiser EM; Dören M
Hum Reprod Update; 2005; 11(6):561-73. PubMed ID: 16150812
[TBL] [Abstract][Full Text] [Related]
4. Estrogen and combined estrogen-progestogen therapy in the menopause and breast cancer.
La Vecchia C
Breast; 2004 Dec; 13(6):515-8. PubMed ID: 15563861
[TBL] [Abstract][Full Text] [Related]
5. Hormone therapy and breast cancer risk.
Foidart JM; Desreux J; Pintiaux A; Gompel A
Climacteric; 2007 Oct; 10 Suppl 2():54-61. PubMed ID: 17882674
[TBL] [Abstract][Full Text] [Related]
6. Cancer issues.
Marsden J; Sturdee D
Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):87-107. PubMed ID: 19036643
[TBL] [Abstract][Full Text] [Related]
7. Benefits and risks of long-term low-dose oral continuous combined hormone therapy.
van de Weijer PH; Mattsson LA; Ylikorkala O
Maturitas; 2007 Mar; 56(3):231-48. PubMed ID: 17034966
[TBL] [Abstract][Full Text] [Related]
8. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
[TBL] [Abstract][Full Text] [Related]
9. Postmenopausal hormone therapy and breast cancer: what is the problem?
Kenemans P
Maturitas; 2005 May; 51(1):75-82. PubMed ID: 15883112
[TBL] [Abstract][Full Text] [Related]
10. Postmenopausal hormone therapy and risk of breast cancer.
Chen FP
Chang Gung Med J; 2009; 32(2):140-7. PubMed ID: 19403003
[TBL] [Abstract][Full Text] [Related]
11. Interactions between body mass index and hormone therapy and postmenopausal breast cancer risk (United States).
Li CI; Malone KE; Daling JR
Cancer Causes Control; 2006 Jun; 17(5):695-703. PubMed ID: 16633917
[TBL] [Abstract][Full Text] [Related]
12. WHI risks: any relevance to menopause management?
Burger HG
Maturitas; 2007 May; 57(1):6-10. PubMed ID: 17368974
[TBL] [Abstract][Full Text] [Related]
13. Postmenopausal hormone therapy and the risk of breast cancer: the view of an epidemiologist.
Li CI
Maturitas; 2004 Sep; 49(1):44-50. PubMed ID: 15351095
[TBL] [Abstract][Full Text] [Related]
14. Climacteric medicine: European Menopause and Andropause Society (EMAS) statements on postmenopausal hormonal therapy.
Skouby SO; Barlow D; Samsioe G; Gompel A; Pines A; Al-Azzawi F; Graziottin A; Hudita D; Rozenberg S;
Maturitas; 2004 May; 48(1):19-25. PubMed ID: 15223104
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer risk during hormone therapy: experimental versus clinical data.
Ruan X; Seeger H; Mueck AO
Minerva Endocrinol; 2012 Mar; 37(1):59-74. PubMed ID: 22382615
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer and hormonal therapy.
Conner P; Lundström E; von Schoultz B
Clin Obstet Gynecol; 2008 Sep; 51(3):592-606. PubMed ID: 18677153
[TBL] [Abstract][Full Text] [Related]
17. Progestogens in postmenopausal hormone therapy and the risk of breast cancer.
Lambrinoudaki I
Maturitas; 2014 Apr; 77(4):311-7. PubMed ID: 24485796
[TBL] [Abstract][Full Text] [Related]
18. Postmenopausal hormone therapy: from monkey glands to transdermal patches.
Davis SR; Dinatale I; Rivera-Woll L; Davison S
J Endocrinol; 2005 May; 185(2):207-22. PubMed ID: 15845914
[TBL] [Abstract][Full Text] [Related]
19. Menopause and stroke and the effects of hormonal therapy.
Lobo RA
Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
[TBL] [Abstract][Full Text] [Related]
20. Increased risk of recurrence after hormone replacement therapy in breast cancer survivors.
Holmberg L; Iversen OE; Rudenstam CM; Hammar M; Kumpulainen E; Jaskiewicz J; Jassem J; Dobaczewska D; Fjosne HE; Peralta O; Arriagada R; Holmqvist M; Maenpaa J;
J Natl Cancer Inst; 2008 Apr; 100(7):475-82. PubMed ID: 18364505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]